novel strategies to evaluate biomarkers of interest in multiple myeloma
Published 1 year ago • 56 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
1:35
the value of ctcs and cfdna as novel biomarkers in multiple myeloma
-
0:57
novel therapeutic strategies in all
-
5:22
novel target antigens to improve the efficacy of immunotherapeutics in multiple myeloma
-
13:23
novel therapeutics in multiple myeloma
-
2:33
identifying novel biomarkers and advancing the classification system in cll
-
1:21
novel targets and the future role of combinations for myeloma
-
4:16
the novel bioactive peptide qub-2392 shows anti-leukemic effects in leukemia cell lines
-
3:58
meet caroline: a childhood leukemia survivor
-
16:35
key highlights in mpns at ash 2023: novel agents & combinations, ongoing clinical trials, and more
-
28:05
identification of novel protein biomarkers in the era of precision medicine oncology
-
2:48
novel targets in multiple myeloma
-
4:03
novel technologies in multiple myeloma and how these are changing the field
-
0:58
minimumm-seq: a novel, minimally invasive approach to characterize myeloma pathology
-
1:53
the future of multiple myeloma treatment
-
2:25
novel ai model for personalized risk stratification & treatment in newly diagnosed multiple myeloma
-
4:58
novel immunotherapies transforming r/r myeloma treatment: bispecifics, car-t cells & more
-
0:56
new additions: novel agents to boost treatment of multiple myeloma
-
3:37
smoldering myeloma: state of the art
-
2:11
beat aml master trial: novel precision medicine approach in aml
-
1:19
the importance of novel targets in myeloma
-
1:24
highlights from the 2016 european multiple myeloma academy (emma) and overview of emma 2017
-
2:38
looking forward to eha 2023: cartitude-4, bispecifics, novel combinations and more